All Stories

  1. PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse

    Article • Current Neuropharmacology, August 2026, Bentham Science Publishers

    Prof. Abdalla Bowirrat, Alireza Sharafshah, Professor kenneth Blum, Rajendra Badgaiyan

  2. Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety

    Article • Current Pharmaceutical Biotechnology, March 2026, Bentham Science Publishers

    Prof. Abdalla Bowirrat, Professor kenneth Blum, Prof. Sergio Schmidt, Professor Aviv Weinstein, ROSSANO FIORELLI, Rajendra Badgaiyan, Alireza Sharafshah

  3. In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder

    Article • Current Neuropharmacology, July 2025, Bentham Science Publishers

    Alireza Sharafshah, Professor kenneth Blum, Prof. Sergio Schmidt, Rajendra Badgaiyan, ROSSANO FIORELLI, Prof. Abdalla Bowirrat

  4. Association and in silico investigations of miR‐302c insertion/deletion variant as a novel biomarker with susceptibility to gastric cancer

    Article • Journal of Cellular Biochemistry, June 2019, Wiley

    Alireza Sharafshah

  5. Association study of rs10768683 and rs968857 polymorphisms with transfusion-dependent thalassemia (TDT) in a southern Iranian population

    Article • Nucleosides Nucleotides & Nucleic Acids, January 2019, Taylor & Francis

    Mahdi Bijanzadeh, Alireza Sharafshah